Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura H Tang

Showing results (71-80 of 172) with videos related to

Pageof 18
Sort By:
Plos One|November 24, 2016
CDH1 Missense Variant c.1679C>G (p.T560R) Completely Disrupts Normal Splicing through Creation of a Novel 5' Splice SiteZarina Yelskaya, Ruben Bacares, Erin Salo-Mullen, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|October 28, 2018
Limited role of Chromogranin A as clinical biomarker for pancreatic neuroendocrine tumorsAlessandra Pulvirenti, Deepthi Rao, Caitlin A Mcintyre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2012
Attenuation of the retinoblastoma pathway in pancreatic neuroendocrine tumors due to increased cdk4/cdk6Laura H Tang, Tanupriya Contractor, Richard Clausen, et al.
Cancer|March 23, 2012
A phase 2 study of the insulin-like growth factor-1 receptor inhibitor MK-0646 in patients with metastatic, well-differentiated neuroendocrine tumorsDiane L Reidy-Lagunes, Efsevia Vakiani, Michal F Segal, et al.
Annals of Surgical Oncology|November 10, 2006
Carcinoid of the rectum risk stratification (CaRRS): a strategy for preoperative outcome assessmentBridget N Fahy, Laura H Tang, David Klimstra, et al.
Annals of Surgical Oncology|February 13, 2007
Carcinoid of the rectum risk stratification (CaRRs): a strategy for preoperative outcome assessmentBridget N Fahy, Laura H Tang, David Klimstra, et al.
Journal of the American College of Surgeons|July 15, 2022
Validation of the Memorial Sloan Kettering Gastric Cancer Post-Resection Survival Nomogram: Does It Stand the Test of Time?Masaya Nakauchi, Colin M Court, Laura H Tang, et al.
Cancer|March 15, 2006
Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosaRohit Bhargava, Beiyun Chen, David S Klimstra, et al.
Cancer Research|July 14, 2019
Integrative Genomic Characterization Identifies Molecular Subtypes of Lung CarcinoidsSaurabh V Laddha, Edaise M da Silva, Kenneth Robzyk, et al.
Plos One|August 15, 2015
Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction CancerYelena Y Janjigian, Efsevia Vakiani, Geoffrey Y Ku, et al.
Pageof 18

Showing results (71-80 of 172) with videos related to

Sort By:
Pageof 18
Plos One|November 24, 2016
CDH1 Missense Variant c.1679C>G (p.T560R) Completely Disrupts Normal Splicing through Creation of a Novel 5' Splice SiteZarina Yelskaya, Ruben Bacares, Erin Salo-Mullen, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|October 28, 2018
Limited role of Chromogranin A as clinical biomarker for pancreatic neuroendocrine tumorsAlessandra Pulvirenti, Deepthi Rao, Caitlin A Mcintyre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2012
Attenuation of the retinoblastoma pathway in pancreatic neuroendocrine tumors due to increased cdk4/cdk6Laura H Tang, Tanupriya Contractor, Richard Clausen, et al.
Cancer|March 23, 2012
A phase 2 study of the insulin-like growth factor-1 receptor inhibitor MK-0646 in patients with metastatic, well-differentiated neuroendocrine tumorsDiane L Reidy-Lagunes, Efsevia Vakiani, Michal F Segal, et al.
Annals of Surgical Oncology|November 10, 2006
Carcinoid of the rectum risk stratification (CaRRS): a strategy for preoperative outcome assessmentBridget N Fahy, Laura H Tang, David Klimstra, et al.
Annals of Surgical Oncology|February 13, 2007
Carcinoid of the rectum risk stratification (CaRRs): a strategy for preoperative outcome assessmentBridget N Fahy, Laura H Tang, David Klimstra, et al.
Journal of the American College of Surgeons|July 15, 2022
Validation of the Memorial Sloan Kettering Gastric Cancer Post-Resection Survival Nomogram: Does It Stand the Test of Time?Masaya Nakauchi, Colin M Court, Laura H Tang, et al.
Cancer|March 15, 2006
Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosaRohit Bhargava, Beiyun Chen, David S Klimstra, et al.
Cancer Research|July 14, 2019
Integrative Genomic Characterization Identifies Molecular Subtypes of Lung CarcinoidsSaurabh V Laddha, Edaise M da Silva, Kenneth Robzyk, et al.
Plos One|August 15, 2015
Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction CancerYelena Y Janjigian, Efsevia Vakiani, Geoffrey Y Ku, et al.
Pageof 18